Wei Cui | Immunology | Best Researcher Award

Published on by Award and Honors

Prof. Wei Cui | Immunology | Best Researcher Award 

 Researcher | National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | China

Prof. Wei Cui is a distinguished researcher and academic leader in the field of clinical diagnostics and oncology. She currently serves as Vice President of Henan Hospital and Director of the Department of Clinical Laboratory at the Cancer Hospital, Chinese Academy of Medical Sciences. With over three decades of progressive experience, Prof. Cui has become a national authority in tumor immunology, liquid biopsy, and diagnostic standardization. Her career bridges advanced medical research and practical application, contributing significantly to the evolution of cancer diagnosis and treatment in China.

Professional Profile

Scopus

🎓 Education

Prof. Cui began her academic journey with a Bachelor’s degree in Clinical Medicine from Harbin Medical University. She further pursued a Master’s degree in Experimental Diagnostics and a Ph.D. in Internal Medicine Oncology, both from the prestigious Peking Union Medical College. To enhance her global perspective, she completed postdoctoral training at Harvard University’s Children’s Hospital Boston, focusing on advanced clinical and laboratory research methodologies.

💼 Experience

Her professional trajectory spans over 30 years, starting as a physician at the First Affiliated Hospital of Harbin Medical University. She progressed through multiple research and clinical roles at Peking Union Medical College Hospital before moving into leadership positions at the Cancer Hospital of the Chinese Academy of Medical Sciences. Since 2024, she has been serving as Vice President at Henan Hospital, while continuing her research and administrative duties. Her roles have evolved from assistant researcher to department director and now, institutional leader, underscoring her commitment to scientific excellence and clinical innovation.

🔬 Research Interests

Prof. Cui’s core research lies in tumor biomarker discovery, circulating tumor cells (CTC) detection, tumor immune microenvironment, and personalized cancer diagnostics. She has led numerous high-impact research projects funded by the National Natural Science Foundation of China and the Ministry of Science and Technology. Her work emphasizes translational medicine, bridging the gap between laboratory breakthroughs and clinical practice, especially in immunotherapy and cancer screening technologies.

🏆 Honors

Prof. Cui has received numerous national honors, including the Huaxia Medical Science and Technology Award and the Science and Technology Awards from the Chinese Preventive Medicine Association and the Chinese Medical Association. She has also been a key contributor to the development of national clinical standards, issuing multiple authoritative guidelines under the Ministry of Health and professional medical societies. Her innovations in diagnostic methods have been granted national patents, reflecting her impact on both scientific and practical aspects of cancer care.

📚 Top Noted Publications

Title: A Wireless Cytosensor Based on a Bionic Dandelion Isothermal Amplification System for Ultrasensitive Detection of Circulating Tumor Cells
Journal: ACS Nano
Year of Publication: 2025

Title: The Degree of Refinement of Immune Cell Subsets Detection by Multi-Parameter Flow Cytometry Should Advance with the Times
Type: Review
Year of Publication: 2025

Title: Single Circulating Tumor Cell Sequencing Based on Improved High-Porosity Membranes and Nanoporous Microchambers
Journal: Biosensors and Bioelectronics
Year of Publication: 2025

Title: ALKBH5-Mediated m6A Regulates the Alternative Splicing Events of SRSF10 in Ovarian Cancer
Journal: Cancer Gene Therapy
Year of Publication: 2025

Title: External Quality Assessment-Based Tumor Marker Harmonization Simulation; Insights in Achievable Harmonization for CA 15-3 and CEA
Journal: Clinical Chemistry and Laboratory Medicine
Year of Publication: 2025

Title: Global Research Trends of Immunosenescence and Immunotherapy: A Bibliometric Study
Journal: Human Vaccines & Immunotherapeutics
Year of Publication: 2025
Citations: 1

Conclusion

Prof. Wei Cui stands at the forefront of clinical oncology research in China, combining scientific rigor with a vision for practical healthcare impact. Her work has advanced cancer diagnostics, established national clinical standards, and fostered interdisciplinary collaboration. With continued dedication and innovation, Prof. Cui remains a vital force in shaping the future of precision medicine and public health diagnostics.

Dr Janelle Darby | Gynecologic Oncology | Best Researcher Award |

Published on by Award and Honors

Dr. Janelle Darby | Gynecologic Oncology | Best Researcher Award

Assistant Professor, at Atrium Health Wake Forest Baptist Medical Center, United States

Dr. Janelle Pakish Darby, MD, MS, is an accomplished Assistant Professor in the Department of Obstetrics and Gynecology at the Wake Forest School of Medicine. She earned her MD from the University of Washington School of Medicine and a Master of Science from the University of Texas Health Science Center at Houston. Dr. Darby’s research focuses on gynecologic oncology, specifically endometrial cancer, with a notable emphasis on the immune microenvironment of microsatellite instable endometrial cancer. Her academic journey includes postdoctoral training at prestigious institutions like Dartmouth-Hitchcock Medical Center and MD Anderson Cancer Center. Throughout her career, Dr. Darby has received numerous honors, including the Felix Rutledge Fellow award and the Best Abstract on Gynecologic Oncology Award. She is actively involved in advancing medical education through her innovative work in developing gynecologic oncology curricula and her participation in leadership programs such as the Association of Professors of Gynecology and Obstetrics (APGO) Academic Scholars and Leaders Program. Dr. Darby’s contributions to both research and education make her a distinguished figure in her field.

Professional Profile

Scopus

Orcid

Education 🎓

Dr. Janelle Pakish Darby earned her Bachelor of Arts in Biology from the University of Pennsylvania in 2006, before pursuing her MD at the University of Washington School of Medicine in 2010. She further advanced her academic credentials by obtaining a Master of Science from the University of Texas Health Science Center at Houston in 2016. Her research thesis, titled “The Immune Microenvironment of Microsatellite Instable Endometrial Cancer,” reflects her academic dedication to advancing the understanding of cancer biology.

Experience 💼

Dr. Darby is currently an Assistant Professor at the Wake Forest School of Medicine in the Department of Obstetrics and Gynecology, where she has been shaping the next generation of medical professionals since 2018. Prior to this role, she completed a residency in Obstetrics and Gynecology at Dartmouth-Hitchcock Medical Center and a fellowship in Gynecologic Oncology at MD Anderson Cancer Center. Her professional journey is a testament to her commitment to patient care and academic excellence.

Research Interest 🔬

Dr. Darby’s research primarily focuses on gynecologic oncology, with a particular interest in endometrial cancer. She has extensively studied the immune microenvironment of cancer, specifically microsatellite instable endometrial cancer, contributing to the growing body of knowledge surrounding cancer immunology. Her expertise in cancer diagnostics and treatment positions her as a leader in the field, working toward improving patient outcomes through novel approaches in gynecologic oncology.

Award 🏅

Dr. Darby has received numerous honors throughout her career. She was awarded the SPARX/CHAP Participation Award in 2008 for her commitment to community health, followed by the Felix Rutledge Fellow recognition at MD Anderson Cancer Center in 2012. In 2013, she was awarded the Best Abstract on Gynecologic Oncology Award at the AAGL Global Congress on Minimally Invasive Gynecology, underscoring her academic excellence and contributions to the field of gynecology.

Top Noted Publication 📑

Title: A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers

Authors:

Laurel K. Berry

Ashok K. Pullikuth

Kristen L. Stearns

Julia Chifman

Lance David Miller

Journal: Journal of Translational Medicine

Year of Publication: 2024

Citations: Not yet available (as of the current year)

Index: Journal of Translational Medicine

Conclusion

Dr. Janelle Pakish Darby is a highly qualified and dedicated professional with a solid track record in academic and clinical research. Her work in gynecologic oncology and her involvement in education and leadership make her a strong contender for the Best Researcher Award. While her research output and funding could be further enhanced, her expertise, leadership, and potential for future contributions to cancer research position her as an exceptional candidate. Expanding her research network and publications would solidify her standing as a leader in her field.